MITOKINE

Welcome to the Brand page for “MITOKINE”, which is offered here for Pharmaceutical preparation for treating mitochondrial disorders, and diseases or conditions relating to mitochondrial dysfunction or deficiencies including obesity, diabetes, metabolic syndrome, and hypoglycemia; pharmaceutical namely oral, inhalational, parenteral, topical pharmaceuticals containing proteins, protein kinase or phosphatas; nutraceuticals, vitamins, minerals, nutritional and dietary supplements for the treatment of mitochondria disorders, deficiencies or conditions arising from mitochondrial dysfunction or deficiencies;medical and scientific research in the field of mitochondrial disorders, and diseases or conditions relating to mitochondrial dysfunction or deficiencies including obesity, diabetes, metabolic syndrome, and hypoglycemia; medical research; pharmaceutical research and development;.

Its status is currently believed to be active. Its class is unavailable. “MITOKINE” is believed to be currently owned by “Mark Tarnopolsky”.